Literature DB >> 22087115

Commentary on the article: Are hepatitis B virus and celiac disease linked?: HBV and celiac disease.

Fabiana Zingone1, Carolina Ciacci.   

Abstract

Entities:  

Keywords:  Celiac; Hepatitis B virus

Year:  2011        PMID: 22087115      PMCID: PMC3206654     

Source DB:  PubMed          Journal:  Hepat Mon        ISSN: 1735-143X            Impact factor:   0.660


× No keyword cloud information.
Dear Editor, The recent paper from Leonardi and La Rosa (2010) aimed to establish the prevalence of celiac disease (CD) in patients with chronic hepatitis B (HBV) infection [1]. Previous studies suggest that chronic hepatitis C (HCV) could trigger immunological gluten intolerance in susceptible patients [2]. This hypothesis, however, is not yet supported by sufficient scientific evidence. Similarly, the possible induction of CD in patients treated with interferon (IFN) therapy is supported in literature only by case reports [3]. Moreover, CD affects as much as 1% of the general population [4], and it is possible that the association described in some papers is the result of incidental findings in a population most studied for the underlying disease. Although the study by Leonardi and La Rosa (2010) was unable to disclose any association between CD and HBV infection, it represents an interesting starting point. The study does have some limitations, particularly a small sample size, a very young average age of participants, and an overrepresentation of men in the sample. In fact, a typical population affected with CD is mostly made up of young adults, with twice as many women as men. In this more typical population, a diagnosis of CD is made according to the presence of EMA and antitransglutaminase IgA in the blood and then an intestinal biopsy. The relationship between CD and hepatitis viruses is intriguing. Previous studies have indicated a defective response to the hepatitis B vaccine in CD. It has been postulated that a primary role of human leukocyte antigen (HLA) genotype DQ2 is that it is predisposed to low immunity to recombinant hepatitis B vaccine [5]. Other studies have postulated a possible role of gluten intake at the time of vaccination [6]. Therefore a larger study should be designed to investigate the prevalence of CD in individuals with HBV and HCV and the possible activation of CD with IFN therapy. Such a study should also include an analysis of the HLA genotype, which seems to have a principal role in this association.
  5 in total

1.  Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.

Authors:  L E Adinolfi; E Durante Mangoni; A Andreana
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

2.  Response to hepatitis B vaccination in patients with celiac disease.

Authors:  Emel Ahishali; Gungor Boztas; Filiz Akyuz; Duygu Ibrisim; Sule Poturoglu; Binnur Pinarbasi; Sadakat Ozdil; Zeynel Mungan
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

Review 3.  The liver in celiac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

4.  Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease.

Authors:  Eva Nemes; Eva Lefler; László Szegedi; Anikó Kapitány; Judit B Kovács; Márta Balogh; Katalin Szabados; Judit Tumpek; Sándor Sipka; Ilma R Korponay-Szabó
Journal:  Pediatrics       Date:  2008-06       Impact factor: 7.124

5.  Are hepatitis B virus and celiac disease linked?

Authors:  Salvatore Leonardi; Mario La Rosa
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.